Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2005
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605960A2 Use of secretin and secretin analogs to treat affective disorders
12/21/2005EP1605959A1 Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis
12/21/2005EP1605957A1 The use of lupin conglutin for the treatment of type ii diabetes
12/21/2005EP1605900A2 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
12/21/2005EP1605899A2 Compositions for induction of a therapeutic response
12/21/2005EP1605897A2 Polyethelene glycol link glp-1 compounds
12/21/2005EP1605895A2 Oral insulin therapies and protocol
12/21/2005EP1605894A2 Oxytocin controlled release formulations and methods of using same
12/21/2005EP1605893A2 Trans-membrane-antibody induced inhibition of apoptosis
12/21/2005EP1605892A2 Combination of an aldosterone receptor antagonist and an anti-diabetic agent
12/21/2005EP1605862A2 Collagen compositions and biomaterials
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1509087A4 Treatment for diabetes
12/21/2005EP1402267B1 Chp for use as marker for sepsis
12/21/2005EP1379547B1 Modified cyclosporin as a pro-drug and use thereof as a medicament
12/21/2005EP1373366B1 Multi-arm block copolymers and pharmaceutical compositions
12/21/2005EP1352030B1 Impact modified polyamide composition
12/21/2005EP1341904B1 Zipper protein kinase and uses thereof
12/21/2005EP1335931B1 Derivatisation of proteins in aqueous solution
12/21/2005EP1307473B1 Purification of hbv antigens for use in vaccines
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1261625B1 Memno peptides, a process for their preparation and their use
12/21/2005EP1228097B1 Antimicrobial activity of the first cationic cluster of human lactoferrin
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1220934B1 Methods for making recombinant proteins using apoptosis inhibitors
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1214600B1 Determination of adrenomedullin-binding proteins
12/21/2005EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders
12/21/2005EP1153928B1 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
12/21/2005EP1150703B1 Chaperonin 10 and beta-interferon therapy of multiple sclerosis
12/21/2005EP1119581B1 USE OF A VECTOR EXPRESSING RB2/p130 FOR PREVENTION OR TREATMENT OF RESTENOSIS OR ATHEROSCLEROTIC PLAQUES
12/21/2005EP1027068B1 Oromucosal cytokine compositions and uses thereof
12/21/2005EP1000167B1 Production of human mutant proteins in human cells by homologous recombination
12/21/2005EP1000143B1 Frazzled nucleotide sequences, expression products, compositions and uses
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0975766B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
12/21/2005EP0920524B1 A short-shafted adenoviral fiber and its use
12/21/2005EP0822988B1 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
12/21/2005EP0809705B1 Nucleic acid-containing composition, preparation and use thereof
12/21/2005EP0783573B1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides
12/21/2005EP0777474B1 Methods for the treatment of inflammatory joint disease
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711109A Positional isomers of PEG IFN alpha 2a
12/21/2005CN1711104A An aqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboemb
12/21/2005CN1711103A Botulinum toxin oral formulation and use thereof for treating peptic ulcers and gastroesophageal reflux disease
12/21/2005CN1711102A Use of dalbavancin compositions in preparation of medicament for treatment of bacterial infections
12/21/2005CN1711101A Treatment of autism and similar disorders
12/21/2005CN1711096A Botulinum toxin formulations for oral administration
12/21/2005CN1711091A The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
12/21/2005CN1711086A Histone deacetylase inhibitors for treating degenerative diseases of the eye
12/21/2005CN1711076A Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
12/21/2005CN1711069A Use of 3-position cyclosporin derivatives for hair growth
12/21/2005CN1709504A localized anesthesia synergistic delay agent
12/21/2005CN1709503A Human lysozyme gel, its preparation and use
12/21/2005CN1709502A Composite joint-improving oral liquid
12/21/2005CN1709501A Chinese herbal medicine for restraining drug addict, and its preparing method
12/21/2005CN1709500A Chinese herbal medicine oral liquid for treating digestive system ulcer, and its preparing method
12/21/2005CN1709499A Chinese medicine medicine oral liquid for treating digestive system cancer, and its preparing method
12/21/2005CN1233185C Method for establishing mobile station connection in cellular telecommunications system
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232637C Live scorpion enzyme and its preparing method
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232537C Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE
12/21/2005CN1232535C GST fusion expression of conotoxin MVII A gene and its use
12/21/2005CN1232534C Heteroprotein of melanoma EPI (Mage-1, HLA-Al) and bacteriophage coat protein and its application
12/21/2005CN1232532C Fibroblast growth factor-2 analogue, producing process and application thereof
12/21/2005CN1232531C Production process and use of epidermal cell chalone
12/21/2005CN1232530C Ethene receptor protein of wheat and its coding sequence
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232303C Use of gene NMESI related to esophageal carcinoma and encoded polypeptide
12/21/2005CN1232302C Compound preparation of Azithromycin and Pidotimod
12/21/2005CN1232301C Compound preparation of valvciclovir HCL and Pidotimod
12/21/2005CN1232300C Left ofloxacin and Pidotimod compound preparation
12/21/2005CN1232244C Stable non-aqueous single phase viscose carrier and formulations utilizing such carrier
12/21/2005CA2510887A1 A method for treating inflammatory bowel disease by oral administration of il-10
12/20/2005US6977296 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005US6977244 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/20/2005US6977242 Two gonadotropin releasing hormones and a method to isolate the same
12/20/2005US6977241 SH2 domain binding inhibitors
12/20/2005US6977175 Nucleic acids encoding lin-37 and uses thereof
12/20/2005US6977174 Circular DNA molecule with conditional origin of replication, method for preparing the same and use thereof in gene therapy
12/20/2005US6977169 Administering neuraminidase
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977087 Administering to the respiratory system of a patient or animal hormone aerodynamically light particles, wherein particles are delivered and deposited to patient's or animal's lungs and hormone is released in patient's or animal's blood stream
12/20/2005US6977080 administering intrapericardially a neurotoxin; reducing the previously required daily antiarrhythmic drug, reducing need for pacemakers
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005US6977077 Method of increasing bone toughness and stiffness and reducing fractures
12/20/2005US6977074 to an antigen by sustained release to the lymphatic system; cytotoxic T lymphocytes; immunization; drug delivery
12/20/2005US6977072 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005US6977070 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
12/20/2005US6977069 Contain at least two M. tuberculosis antigens; for vaccines, diagnosis, treatment
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
1 ... 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 ... 3163